> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Authorizes Novavax Covid-19 Booster
- URL: https://www.fdaweb.com/fda-authorizes-novavax-covid-19-booster/
- Published: 2022-10-19T12:00:00.000Z
- Updated: 2026-09-14T18:03:36.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5153010

FDA has granted Novavax an [emergency use authorization](https://www.fda.gov/media/159902/download?ref=fdaweb.com) for its Novavax Covid‑19 Vaccine, Adjuvanted as a first booster dose (0.5 mL) for certain individuals at least six months after completing their primary vaccination with an authorized or approved Covid-19 vaccine. According to the agency, the booster is authorized for:

- Individuals 18 years of age and older for whom an FDA-authorized mRNA bivalent Covid-19 booster vaccine is not accessible or clinically appropriate
- Individuals 18 years of age and older who elect to receive the Novavax Covid-19 Vaccine because they would otherwise not receive a booster dose of a Covid-19